7-氟-1,2,3,4-四氢萘-2-胺 | 173998-63-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 中文名称: 7-氟-1,2,3,4-四氢萘-2-胺
• 英文名称: 7-Fluoro-1,2,3,4-tetrahydronaphthalen-2-amine
• CAS: 173998-63-5
• 化学式: C₁₀H₁₂FN
• mdl: MFCD06739166
• 分子量: 165.21
• InChiKey: WWEGVSHNWGNDIX-UHFFFAOYSA-N

物化性质

• 沸点：
  246.3±40.0 °C(Predicted)
• 密度：
  1.115±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2921450090

文献信息

• Phosphonate analogs of HIV integrase inhibitor compounds
  申请人：Cai R. Zhenhong

  公开号：US20060116356A1

  公开（公告）日：2006-06-01

  Novel HIV integrase inhibitor compounds having at least one phosphonate group, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.

  本发明揭示了至少具有一个膦酸酯基团的新型HIV整合酶抑制剂化合物，其保护中间体以及用于抑制HIV整合酶的方法。
• Pre-organized tricyclic integrase inhibitor compounds
  申请人：GILEAD SCIENCES, INC.

  公开号：US20040157804A1

  公开（公告）日：2004-08-12

  Tricyclic compounds according to the structure below, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed. 1 A 1 and A 2 are moieties forming a five, six, or seven membered ring. L is a bond or a linker connecting a ring atom of Ar to N. X is O, S, or substituted nitrogen. Ar is aryl or heteroaryl. Q is N, + NR, or CR 4 . The aryl carbons may be independently substituted with substituents other than hydrogen. The compounds may include prodrug moieties covalently attached at any site.

  本发明揭示了以下结构的三环化合物、其保护中间体以及抑制HIV整合酶的方法。其中，1A1和A2是形成五、六或七元环的基团。L是连接Ar环原子和N原子的键或连接器。X为O、S或取代氮。Ar为芳基或杂环芳基。Q为N、+NR或CR4。芳基碳可以独立地被取代为除氢以外的取代基。化合物可以包括共价连接在任何位点的前药基团。
• Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds
  申请人：Cai R. Zhenhong

  公开号：US20080076738A1

  公开（公告）日：2008-03-27

  Novel HIV integrase inhibitor compounds having at least one phosphonate group, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.

  本发明公开了至少具有一个膦酸酯基团的新型HIV整合酶抑制剂化合物、其受保护的中间体以及用于抑制HIV整合酶的方法。
• Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitors
  申请人：CTXT PTY LTD

  公开号：US10005792B2

  公开（公告）日：2018-06-26

  A compound of formula (1a), (1b) or (1c) wherein: n is 1 or 2; RN is H or Me; R1 is optionally one or more halo or methyl groups; R2a and R2b are independently selected from the group consisting of: (i) F; (ii) H; (iii) Me; and (iv) CH2OH; R2c and R2d (if present) are independently selected from the group consisting of: (i) F; (ii) H; (iii) Me; and (iv) CH2OH; R3a and R3b are independently selected from H and Me; R4a is selected from OH, —NH2, —C(═O)NH2, and —CH2OH; R4b is either H or Me; R5 is either H or Me; A is either (i) optionally substituted phenyl; (ii) optionally substituted naphthyl; or (iii) optionally substituted C5-12 heteroaryl.

  式（1a）、（1b）或（1c）化合物 其中：n 为 1 或 2；RN 为 H 或 Me；R1 可任选为一个或多个卤代或甲基；R2a 和 R2b 独立选自以下组：(i) F；(ii) H；(iii) Me；和 (iv) CH2OH；R2c 和 R2d（如存在）独立选自以下组：(i) F；(ii) H；(iii) Me；和 (iv) CH2OH；R3a 和 R3b 独立选自 H 和 Me；R4a 选自 OH、-NHH 或 Me：(R3a和R3b独立选自H和Me；R4a选自OH、-NH2、-C(═O)NH2和-CH2OH；R4b不是H就是Me；R5不是H就是Me；A是(i)任选取代的苯基；(ii)任选取代的萘基；或(iii)任选取代的C5-12杂芳基。
• Substituted ureas and methods of making and using same
  申请人：MEBIAS DISCOVERY, INC.

  公开号：US10683283B2

  公开（公告）日：2020-06-16

  The invention relates to substituted ureas, and compositions comprising the same, which in certain embodiments are useful for treating and/or preventing pain in a subject in need thereof.

  本发明涉及取代的脲和包含取代的脲的组合物，在某些实施例中，取代的脲和组合物可用于治疗和/或预防有需要的受试者的疼痛。